PERRONE, ANNA MYRIAM
 Distribuzione geografica
Continente #
AS - Asia 8.786
NA - Nord America 7.924
EU - Europa 7.004
AF - Africa 787
SA - Sud America 669
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 25.182
Nazione #
US - Stati Uniti d'America 7.809
SG - Singapore 2.731
CN - Cina 2.633
IT - Italia 2.470
VN - Vietnam 1.384
GB - Regno Unito 793
DE - Germania 784
HK - Hong Kong 741
SE - Svezia 684
BR - Brasile 514
IN - India 408
NL - Olanda 404
KR - Corea 387
FR - Francia 335
CI - Costa d'Avorio 277
RU - Federazione Russa 272
IE - Irlanda 245
FI - Finlandia 178
TG - Togo 163
CH - Svizzera 162
SC - Seychelles 154
UA - Ucraina 147
AT - Austria 108
BE - Belgio 95
ID - Indonesia 91
JO - Giordania 88
JP - Giappone 85
BG - Bulgaria 74
ZA - Sudafrica 73
AR - Argentina 63
CA - Canada 58
NG - Nigeria 56
TR - Turchia 49
EE - Estonia 47
PL - Polonia 44
ES - Italia 43
MX - Messico 41
BD - Bangladesh 40
EC - Ecuador 30
PK - Pakistan 30
IR - Iran 26
LT - Lituania 19
IQ - Iraq 18
MA - Marocco 17
CZ - Repubblica Ceca 15
CO - Colombia 14
DZ - Algeria 14
HR - Croazia 14
PH - Filippine 14
CL - Cile 13
EG - Egitto 12
SK - Slovacchia (Repubblica Slovacca) 12
RO - Romania 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
GR - Grecia 9
AU - Australia 8
PE - Perù 8
UY - Uruguay 8
UZ - Uzbekistan 8
PY - Paraguay 7
AL - Albania 6
PT - Portogallo 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
MY - Malesia 5
PA - Panama 4
SN - Senegal 4
CR - Costa Rica 3
DK - Danimarca 3
HU - Ungheria 3
KE - Kenya 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GA - Gabon 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TN - Tunisia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
Totale 25.158
Città #
Singapore 1.796
Ashburn 1.220
Hefei 871
Hong Kong 738
Chandler 698
Bologna 656
Southend 596
Fairfield 542
Santa Clara 418
Seoul 386
Ho Chi Minh City 347
Beijing 302
Hanoi 297
Boardman 286
Abidjan 276
Dallas 275
Princeton 244
Dublin 241
Seattle 233
Woodbridge 232
Wilmington 227
Houston 213
Milan 176
Lomé 162
Ann Arbor 161
Cambridge 151
Los Angeles 141
Bern 136
New York 135
Redmond 132
Dong Ket 127
Helsinki 104
Turin 102
Amman 88
Redondo Beach 87
Jacksonville 82
Buffalo 81
Frankfurt am Main 81
Bengaluru 80
Munich 79
Berlin 78
Tokyo 78
Sofia 71
Nanjing 69
Jakarta 63
Amsterdam 61
Vienna 60
Rome 59
Falkenstein 58
Abeokuta 55
Brussels 55
Guangzhou 55
Westminster 55
Nuremberg 53
Padova 52
Chicago 50
São Paulo 50
Florence 49
Lappeenranta 48
Jinan 45
Hyderabad 44
San Diego 44
Ghent 39
Haiphong 39
Shanghai 38
Casalecchio di Reno 37
Des Moines 36
Modena 33
Da Nang 32
Groningen 32
Shenyang 30
Bremen 28
Changsha 28
Düsseldorf 27
Falls Church 27
Warsaw 27
Biên Hòa 26
Hải Dương 26
Xi'an 26
London 25
Medford 25
Saint Petersburg 25
Tongling 25
Ha Long 24
Hebei 24
Johannesburg 24
Paris 24
Turku 24
Brooklyn 23
Mülheim 23
Ninh Bình 23
Denver 22
Thái Nguyên 22
Bari 21
Olalla 21
Parma 21
Bühl 20
Council Bluffs 20
Forlì 20
Mexico City 20
Totale 15.458
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 443
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 376
Prevalenza delle disfunzioni sessuali femminili nelle donne in menopausa con sindrome metabolica. 338
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 338
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 283
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 277
Inducing respiratory complex I impairment elicits an increase in PGC1α in ovarian cancer 270
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 268
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers 267
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 237
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 227
Impact of Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 224
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 217
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 212
Plasma-activated Ringer's Lactate Solution Displays a Selective Cytotoxic Effect on Ovarian Cancer Cells 212
Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review 206
Malignant Bowel Obstruction in Ovarian Cancer Recurrence: The Role of Palliative Surgery in a Decision-Making Process 203
An analysis of clinical, surgical, pathological and molecular characteristics of endometrial cancer according to mismatch repair status. A multidisciplinary approach 202
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance 199
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 197
Potential for Mitochondrial DNA Sequencing in the Differential Diagnosis of Gynaecological Malignancies 197
Androgen receptor expression in the human vagina under different physiological and treatment conditions 195
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results 194
MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer 191
Accuracy of three-dimensional ultrasound in diagnosis and classification of congenital uterine anomalies. 191
Classification systems of endometrial cancer: A comparative study about old and new 191
Results of a phase I-II study on laser therapy for vaginal side effects after radiotherapy for cancer of uterine cervix or endometrium 187
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 187
Le malformazioni vaginali 185
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 184
Spatial Cancer-Immune phenotypes predict shorter recurrence free survival in the NSMP molecular subtype of endometrial carcinoma 183
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 181
Cervical cancer in pregnancy: Analysis of the literature and innovative approaches 180
Mitochondrial DNA sequencing demonstrates clonality of peritoneal implants of borderline ovarian tumors 180
Delaying surgery for patients with a previous SARS-CoV-2 infection 180
Accuracy of 18F-FDG-PET/CT in the pre surgical staging of ovarian cancer. 179
A surgical multi-layer technique for pelvic reconstruction after total exenteration using a combination of pedicled omental flap, human acellular dermal matrix and autologous adipose derived cells 178
Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells 171
Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters. 171
Modulation of RAB7A Protein Expression Determines Resistance to Cisplatin through Late Endocytic Pathway Impairment and Extracellular Vesicular Secretion 171
Pathological and molecular diagnosis of bilateral inguinal lymph nodes metastases from low-grade endometrial adenocarcinoma: a case report with review of the literature 169
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 169
Current methodologies to detect circulating tumor cells: a focus on ovarian cancer 169
L'influenza della menopausa sulle caratteristiche della cefalea. 168
The impairment of sexual function is less distressing for menopausal than for premenopausal women. 168
Effect of long-term testosterone administration on the endometrium of female to male (FtM) transsexuals. 163
Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome 163
Electrochemotherapy pre-treatment in primary squamous vulvar cancer. Our preliminary experience 162
Hysterectomy and Bilateral Salpingoovariectomy in a Transsexual Subject without Visible Scaring. 161
Immunomagnetic enrichment coupled to PAX8/TP53 molecular pathology approach increases sensitivity in the detection of ovarian cancer cells in ascites 160
Valutazione dell'influenza dell'accesso chirurgico sulla sessualità nella donna isterectomizzata. 160
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial. 159
Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. 157
Electrochemotherapy in Vulvar Cancer and Cisplatin Combined with Electroporation. Systematic Review and In Vitro Studies 153
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 153
Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (Leep): A propensity-score matched comparison 151
Single or repeated gonadotropin-releasing hormone agonist treatment avoids hysterectomy in premenopausal women with large symptomatic fibroids with no effects on sexual function. 150
null 150
miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy 150
Potential Prognostic Role of 18F-FDG PET/CT in Invasive Epithelial Ovarian Cancer Relapse. A Preliminary Study 149
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer 147
Clinically Informed Intelligent Classification of Ovarian Cancer Cells by Label-Free Holographic Imaging Flow Cytometry 146
Definitive Radiotherapy in Invasive Vaginal Carcinoma: A Systematic Review 146
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 146
Mitochondrial Chaperonin MCJ Promotes Vulnerability to Ferroptosis of Chemoresistant Ovarian Cancer Cells – Dataset 145
Relevance of ARID1A Mutations in Endometrial Carcinomas 145
Hysterectomy or not for borderline ovarian tumor in menopause? 144
Laparoscopic treatment of interstitial twin pregnancy. 144
Mitochondrial DNA genotyping reveals synchronous nature of endometrial and ovarian cancers 144
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 144
Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report 139
Emerging Role of MicroRNAs in the Therapeutic Response in Cervical Cancer: A Systematic Review 138
Palliative electro-chemotherapy in elderly patients with vulvar cancer: A phase II trial 138
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 138
Testosterone Undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals: hormonal and metabolic effects. 137
Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control 136
Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study) 135
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak 135
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile 135
Palliative Electrochemotherapy in Vulvar Carcinoma: Preliminary Results of the ELECHTRA (Electrochemotherapy Vulvar Cancer) Multicenter Study 134
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 133
Distinctive features of blood- and ascitic fluid-derived extracellular vesicles in ovarian cancer patients 132
What is new on ovarian carcinoma: Integrated morphologic and molecular analysis following the new 2020 world health organization classification of female genital tumors 130
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival 128
Effects of Testosterone Undecanoate (TU) Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male (FtM) Transsexuals. 127
Successful Pregnancies, Births, and Children Development Following Oocyte Cryostorage in Female Cancer Patients During 25 Years of Fertility Preservation 126
A Planned Multidisciplinary Surgical Approach to Treat Primary Pelvic Malignancies 125
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma 124
Testosterone al femminile. 124
Effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male transsexuals (FtM): 124
Everything You Always Wanted to Know about Sarcopenia but Were Afraid to Ask: A Quick Guide for Radiation Oncologists (Impact of Sarcopenia in Radiotherapy: The AFRAID Project) 123
Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points. 123
Primary or Interval Debulking Surgery for Advanced Endometrial Cancer with Carcinosis: A Systematic Review and Individual Patient Data Meta-Analysis of Survival Outcomes 123
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment 122
Hormonal and metabolic effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals. 122
Electrochemotherapy of skin metastases from malignant melanoma: a PRISMA-compliant systematic review 121
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 121
Electrochemotherapy can be used as palliative treatment in patients with repeated loco-regional recurrence of squamous vulvar cancer: A preliminary study 121
Machine Learning Applied to Pre-Operative Computed-Tomography-Based Radiomic Features Can Accurately Differentiate Uterine Leiomyoma from Leiomyosarcoma: A Pilot Study 120
Development of a risk score based on clinical–pathological features to predict the presence of germline BRCA1/2 pathogenic variants in ovarian cancer patients 118
Totale 17.359
Categoria #
all - tutte 76.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.024 0 0 0 0 0 58 17 94 231 145 110 369
2021/20222.635 107 82 96 258 204 96 94 352 141 186 618 401
2022/20233.638 278 449 158 371 383 311 176 211 620 123 281 277
2023/20241.518 91 181 84 145 134 264 65 133 50 126 120 125
2024/20256.407 354 657 592 404 716 317 631 284 222 536 518 1.176
2025/20268.053 1.710 1.894 1.429 1.252 1.458 310 0 0 0 0 0 0
Totale 25.823